HKMA Clarifies Regulatory Treatment of Measures to Ease COVID Impact

25 May, 2020 18:07
source: Singularity Financial

Singularity Financial Hong Kong May 25, 2020 – HKMA published a circular, addressed to authorized institutions, on the application of the Basel Committee guidance on certain COVID-related measures.

The Basel Committee issued its guidance on March 27, 2020 and April 03, 2020 with the aim to alleviate the impact of COVID-19 on the global banking system. The related Basel Committee guidance and this HKMA circular provide clarifications regarding the regulatory capital treatment of loan guarantee measures, the provisioning of expected credit losses (ECLs) under HKFRS/IFRS 9, and the timeline for implementing margin requirements for non-centrally cleared OTC derivatives.

To ensure that authorized institutions reflect the risk-reducing effect of the extraordinary support measures related to COVID when calculating their regulatory capital requirements, HKMA has published several technical clarifications, which are enclosed as an Annex to this circular. These clarifications address the reporting requirements as well as the capital treatment of the associated loans under the standardized credit risk approach and the internal ratings-based approach.

In this circular, HKMA also announced that it will defer the final two implementation phases of margin requirements for non-centrally cleared OTC derivatives by an additional year. With this extension, the final implementation phase will start on September 01, 2022, at which point the covered entities with an average aggregate notional amount (AANA) of non-centrally cleared OTC derivatives greater than HKD 60 billion will be subject to the requirements. As an intermediate step, from September 01, 2021, covered entities with an AANA of non-centrally cleared OTC derivatives greater than HKD 375 billion will be subject to the requirements.

With respect to the ECL provisioning, HKMA expects institutions to continue to apply the relevant ECL frameworks for accounting purposes. HKMA expects ECL estimates to reflect the mitigating effect of the significant economic support and payment relief measures put in place by public authorities and the banking sector. The provision of relief measures to borrowers should not automatically result in exposures moving from a 12-month ECL to a lifetime ECL measurement. Additionally, institutions are expected to exercise informed judgment and to use the flexibility inherent in HKFRS/IFRS 9, for example, to give due consideration to long-term economic trends in estimating ECL. Finally, HKMA highlighted that it will continue to monitor the banking and supervisory implications of COVID-19 outbreak and coordinate with the BCBS and other relevant standard-setting bodies on responses to the pandemic.